30 AGs Back $465M J&J Verdict In Landmark Opioid Trial
A $465 million judgment against Johnson & Johnson after the first trial in a nationwide wave of opioid-crisis litigation was legally sound and strengthened other lawsuits aimed at holding pharmaceutical companies...To view the full article, register now.
Already a subscriber? Click here to view full article